Literature DB >> 19000902

Caldesmon is essential for cardiac morphogenesis and function: in vivo study using a zebrafish model.

Ping-Pin Zheng1, Lies-Anne Severijnen, Rob Willemsen, Johan M Kros.   

Abstract

The zebrafish homologue of caldesmon is similar to the mammalian low molecular weight caldesmon (l-CaD). In this study, we explored the effects of caldesmon knockdown on vertebrate heart development in vivo. In a zebrafish model caldesmon was knocked down resulting in defective cardiac morphogenesis, muscularization and function. The data provide the first functional assessment of the role of caldesmon in cardiac development in vivo, and indicate that caldesmon is essential for proper cardiac organogenesis and function. Because caldesmon expression remarkably influences cardiac muscularization, the findings are relevant for designing future therapeutic strategies in the regeneration of cardiac damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000902     DOI: 10.1016/j.bbrc.2008.10.165

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

2.  Caldesmon regulates actin dynamics to influence cranial neural crest migration in Xenopus.

Authors:  Shuyi Nie; Yun Kee; Marianne Bronner-Fraser
Journal:  Mol Biol Cell       Date:  2011-07-27       Impact factor: 4.138

3.  Genetic Requirement of talin1 for Proliferation of Cranial Neural Crest Cells during Palate Development.

Authors:  Kana Ishii; Kusumika Mukherjee; Takashi Okada; Eric C Liao
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-03-19

4.  Caldesmon controls stress fiber force-balance through dynamic cross-linking of myosin II and actin-tropomyosin filaments.

Authors:  Shrikant B Kokate; Katarzyna Ciuba; Vivien D Tran; Reena Kumari; Sari Tojkander; Ulrike Engel; Konstantin Kogan; Sanjay Kumar; Pekka Lappalainen
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.